Ph.D
Mohamed Ashraf Momtaz is an experienced analytical chemist with over 13 years in pharmaceutical research and development. He specializes in advanced chromatographic and electrochemical methods supporting therapeutic drug monitoring, pharmacokinetics, and innovative drug detection platforms.
He has contributed significantly to method validation, stress stability studies, and bioequivalence research for various dosage forms, aligning with global regulatory standards (USP, BP, ICH). As Associate Manager of Laboratories Development at EIPICO, he leads multidisciplinary teams and collaborates with CROs to drive pharmaceutical innovation and regulatory compliance.
He is currently pursuing a Ph.D. in Analytical Chemistry at Tanta University and actively reviews peer-reviewed journal submissions, further advancing research quality standards in the pharmaceutical industry.
Peer-reviewer in international scientific journals
Contributor to BP & USP regulatory case studies
Team leader for drug development & analytical method innovation
Laboratory development & technology deployment in pharma industry
1. Prucalopride drug detection using ACH/Ag@rGO nanocomposite → Journal of The Electrochemical Society
2. Voltammetric detection of Ledipasvir using NiO nanoflakes + Activated Charcoal → Journal of The Electrochemical Society
3. QbD-optimized HPLC method for measuring isosorbide dinitrate & sildenafil → Talanta Open (2025)
